Achmea Investment Management B.V. Grows Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Achmea Investment Management B.V. increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSICGet Rating) by 15.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 67,411 shares of the company’s stock after buying an additional 8,915 shares during the period. Achmea Investment Management B.V.’s holdings in Henry Schein were worth $5,877,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. AIA Group Ltd lifted its holdings in shares of Henry Schein by 32.9% in the first quarter. AIA Group Ltd now owns 2,304 shares of the company’s stock valued at $201,000 after purchasing an additional 571 shares in the last quarter. TCW Group Inc. lifted its holdings in shares of Henry Schein by 9.6% in the first quarter. TCW Group Inc. now owns 17,262 shares of the company’s stock valued at $1,505,000 after purchasing an additional 1,514 shares in the last quarter. Empirical Finance LLC purchased a new stake in shares of Henry Schein in the first quarter valued at about $216,000. Virginia Retirement Systems ET AL lifted its holdings in shares of Henry Schein by 89.3% in the first quarter. Virginia Retirement Systems ET AL now owns 233,000 shares of the company’s stock valued at $20,315,000 after purchasing an additional 109,900 shares in the last quarter. Finally, Advisor Partners LLC lifted its holdings in shares of Henry Schein by 51.9% in the first quarter. Advisor Partners LLC now owns 4,334 shares of the company’s stock valued at $378,000 after purchasing an additional 1,481 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Analyst Ratings Changes

HSIC has been the topic of several recent research reports. Credit Suisse Group reduced their price target on shares of Henry Schein from $100.00 to $90.00 and set an “outperform” rating on the stock in a report on Wednesday, August 3rd. Barrington Research reduced their price objective on shares of Henry Schein from $102.00 to $99.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 3rd. UBS Group raised shares of Henry Schein from a “sell” rating to a “neutral” rating and set a $80.00 price objective on the stock in a research note on Monday, August 8th. Robert W. Baird downgraded shares of Henry Schein from an “outperform” rating to a “neutral” rating and reduced their price objective for the company from $103.00 to $88.00 in a research note on Tuesday, June 14th. Finally, The Goldman Sachs Group downgraded shares of Henry Schein from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $93.00 to $85.00 in a research note on Thursday, July 21st. One analyst has rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $85.89.

Henry Schein Stock Performance

Shares of HSIC stock opened at $74.30 on Monday. Henry Schein, Inc. has a one year low of $70.25 and a one year high of $92.68. The company has a 50 day moving average price of $75.66 and a 200 day moving average price of $81.45. The firm has a market capitalization of $10.11 billion, a price-to-earnings ratio of 15.94, a price-to-earnings-growth ratio of 1.98 and a beta of 0.76. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.95 and a current ratio of 1.83.

Henry Schein (NASDAQ:HSICGet Rating) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.16. Henry Schein had a net margin of 5.11% and a return on equity of 15.56%. The company had revenue of $3.03 billion during the quarter, compared to analyst estimates of $3.12 billion. During the same quarter in the prior year, the business earned $1.11 earnings per share. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.85 EPS for the current year.

Henry Schein announced that its board has initiated a stock repurchase program on Thursday, August 18th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to reacquire up to 4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its shares are undervalued.

About Henry Schein

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICGet Rating).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.